Axonics Inc (AXNX)
67.58
-0.09
(-0.13%)
USD |
NASDAQ |
May 17, 16:00
67.58
0.00 (0.00%)
After-Hours: 20:00
Axonics Cash from Investing (TTM): 20.63M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 20.63M |
December 31, 2023 | -116.90M |
September 30, 2023 | -89.01M |
June 30, 2023 | -177.36M |
March 31, 2023 | -119.37M |
December 31, 2022 | -120.35M |
September 30, 2022 | -111.41M |
June 30, 2022 | -12.69M |
March 31, 2022 | -2.429M |
December 31, 2021 | -143.00M |
September 30, 2021 | -142.94M |
Date | Value |
---|---|
June 30, 2021 | -142.90M |
March 31, 2021 | -143.09M |
December 31, 2020 | 9.654M |
September 30, 2020 | 23.02M |
June 30, 2020 | 41.12M |
March 31, 2020 | 53.12M |
December 31, 2019 | 45.29M |
September 30, 2019 | -15.17M |
June 30, 2019 | -29.11M |
March 31, 2019 | -55.84M |
December 31, 2018 | -60.05M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-177.36M
Minimum
Jun 2023
53.12M
Maximum
Mar 2020
-58.65M
Average
-59.06M
Median
Cash from Investing (TTM) Benchmarks
Boston Scientific Corp | -2.375B |
Cutera Inc | 76.81M |
Stereotaxis Inc | 20.11M |
Electromed Inc | -0.79M |
Myomo Inc | -5.527M |